BASEL MEDICAL GROUP LTD (BMGL) Stock Cash Flow
NASDAQ:BMGL - VGG0864B1031 - Common Stock
1.99 USD
+0.01 (+0.51%)
2 USD
+0.01 (+0.5%)
| TTM (2024-12-31) | 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | ||||
|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||||
| Net Income | 149.90K | 2.40M | 2.13M | 2.39M | |||
| Depreciation Amortization | 615.10K | 528.70K | 557.10K | 575.90K | |||
| Change In Working Capital | -2.47M | -594.70K | -238.20K | -269.60K | |||
| Interest Paid | 177.70K | 176.20K | 238.60K | 320.90K | |||
| Taxes Paid | 327.50K | 413.60K | 286.40K | 30.10K | |||
| Other non cash items | 276.20K | 170.70K | 149.50K | 99.70K | |||
| OPERATING CASH FLOW | -1.42M | 2.51M | 2.60M | 2.79M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||||
| Capital Expenditure | -18.40K | -7.90K | -6.20K | -88.50K | |||
| INVESTING CASH FLOW | 36.00K | -7.90K | -6.20K | -88.50K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||||
| Debt Issued/Reduced | -3.32M | -2.92M | -2.34M | -12.16M | |||
| Other Financing Activity | 11.22M | 1.16M | -599.40K | -764.60K | |||
| FINANCING CASH FLOW | 7.90M | -1.77M | -2.94M | -12.92M | |||
| CHANGE IN CASH | 6.50M | 733.60K | -346.20K | -10.22M | |||
| FREE CASH FLOW | |||||||
| Operating Cash Flow | -1.42M | 2.51M | 2.60M | 2.79M | |||
| Capital Expenditure | -18.40K | -7.90K | -6.20K | -88.50K | |||
| FREE CASH FLOW | -1.44M | 2.50M | 2.59M | 2.70M | |||
All data in SGD